The European Union has announced that The Committee of the Permanent Representatives of the Governments of the Member States to the European Union (Coreper) agreed this week on the European Council’s draft regulation that grants an exception to Supplementary Protection Certificates (SPCs).
Researchers from Intel Corp. and UC Berkeley are looking beyond current transistor technology and preparing the way for a new type of memory and logic circuit that could someday be in every computer on the planet.
Engineers at the University of British Columbia have developed a new ultrasound transducer, or probe, that could dramatically lower the cost of ultrasound scanners to as little as $100.
Sensor Electronic Technology, Inc. (“SETi”), a leading global innovator of UV LED products and technology, announced that it has filed a patent infringement lawsuit against both Bolb, Inc. (“Bolb”) and Quantum Egg, Inc.
Blockchain adoption is currently a hot topic for entities operating within the big economies like the USA and China. According a recent market research, most of the blockchain-related patents filed so far are from organizations based within these two jurisdictions.
An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases.
NVIDIA and Arm just announced that they are partnering to bring deep learning inferencing technology to mobile, consumer electronics and the Internet of Things devices. As a result of the partnership, NVIDIA and Arm will integrate NVIDIA’s open-source Deep Learning Accelerator (NVDLA) architecture into Arm’s Project Trillium platform for machine learning.
A district court judge has ruled that ICON Health & Fitness infringed on a Chinese patent related to an elliptical exercise machine and awarded Nautilus Inc. $1.8 million in damages, plus attorney’s fees.
The U.S. Patent and Trademark Office officially published a series of 42 newly granted patents for Apple Inc. on January 30, 2018, wherein five granted patents cover different aspects of Apple's AirPod case.
Roche Chairman Christoph Franz remains confident the Swiss drugmaker can offset revenue declines from patent expired medicines with new drugs, according to an interview published in the Swiss newspaper NZZ am Sonntag.
Emergency treatments could be transformed, saving lives. A highly elastic and adhesive surgical glue that quickly seals wounds without the need for common staples or sutures could transform how surgeries are performed.
UH Researchers Discover New Form of Stretchable Electronics, Sensors and Skins. A team of researchers from the University of Houston has reported a breakthrough in stretchable electronics that can serve as an artificial skin, allowing a robotic hand to sense the difference between hot and cold, while also offering advantages for a wide range of biomedical devices.
Scientists at The University of Manchester have created the world’s first ‘molecular robot’ that is capable of performing basic tasks including building other molecules. The tiny robots, which are a millionth of a millimetre in size, can be programmed to move and build molecular cargo, using a tiny robotic arm.
Cells secrete nanoscale packets called exosomes that carry important messages from one part of the body to another. Scientists from MIT and other institutions have now devised a way to intercept these messages, which could be used to diagnose problems such as cancer or fetal abnormalities.
A team of scientists and engineers at The University of Texas at Austin has invented a powerful tool that rapidly and accurately identifies cancerous tissue during surgery, delivering results in about 10 seconds—more than 150 times as fast as existing technology. The MasSpec Pen is an innovative handheld instrument that gives surgeons precise diagnostic information about what tissue to cut or preserve, helping improve treatment and reduce the chances of cancer recurrence.
Aduro Biotech, Inc. (Nasdaq:ADRO), a biopharmaceutical company with three distinct immunotherapy technologies, today announced that the United States Patent and Trademark Office has issued two patents to Aduro related to the activation of the STING (Stimulator of Interferon Genes) Pathway.
A team of researchers from Chongqing University and the National Center for Nanoscience and Technology, both in China, has developed a sensor that is able to translate eye muscle movement into electrical signals that can be used to type or control an external device.
For the third time this spring, business advocates succeeded in persuading the U.S. Supreme Court to limit forum-shopping by tightening jurisdictional rules that determine where corporate defendants can be sued. In Bristol-Myers Squibb v. Superior Court of California, the court sided with the pharmaceutical company in its battle against a class action brought in California by injured users of Plavix, a blood-thinning drug, even though many of the plaintiffs had little or no connection to the
China’s State Intellectual Property Office, or SIPO, announced that it will grant the University of California, in conjunction with the University of Vienna and Emmanuelle Charpentier, a patent for its CRISPR gene-editing technology. China’s decision comes amidst a long battle between the UC and the Broad Institute over intellectual property rights for the CRISPR technology.
As the commercial drone market expands at an accelerating rate, so does the risk of malicious use of these devices and the need to successfully detect and take counter measures. This is the focus of the most recent PureTech Systems patent approval.
The Windows phone in the patent has a folding screen that would allow it to be used like a tablet, and comes with a mysterious 360-degree mode. While many have discussed the possibility of Windows 10 Mobile being killed off, Microsoft has always denied this. The company has continued to support the platform. Recent events have also supported this claim, including hints of a return to making mobile hardware. A Windows patent shows us how Microsoft envisions the smartphone of the future.
LegoChem Biosciences (“LCB”), a biopharmaceutical company focusing on the research & development of ADCs, based in Daejeon South Korea, announced today that the Company was awarded U.S. Patent No. 14517616, entitled “ANTIBODY-ACTIVE AGENT CONJUGATES AND METHODS OF USE.”
Ethics lawyers raise alarm over constitutional violation if president given special treatment in quickly securing 38 new trademarks to develop potential businesses. China has granted preliminary approval for 38 new Trump trademarks, paving the way for Donald Trump and his family to potentially develop a host of branded businesses from hotels to insurance to bodyguard and escort services.
Genprex, Inc. announced new pre-clinical data which reveal that TUSC2 (formerly known as FUS1, the active anti-cancer agent in OncoprexTM) in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlated with prolonged survival in mice.
BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company, announced that two important new patents were granted extending patent protection around all three of its FDA approved products, Belbuca (buprenorphine) buccal film, Bunavail (buprenorphine and naloxone) buccal film, and Onsolis (fentanyl buccal soluble film), further strengthening BDSI's overall intellectual property position.
Cleveland HeartLab Inc. announces that a new patent U.S. Patent No. 9,575,065 for Myeloperoxidase (MPO) testing has been issued.
Soligenix, announces that its proprietary formulation of synthetic hypericin has been granted a European patent for the treatment of psoriasis. Synthetic hypericin, the active ingredient in SGX301, completed a Phase 2 clinical study demonstrating significant improvement in both Cutaneous T-cell lymphoma (CTCL) and psoriasis.
Emmaus announces the issuance of patent application number 2014-542296, by the Japanese Patent Office for the use of its lead investigative product, pharmaceutical grade L-glutamine (PGLG), for the treatment of diabetes.